This Common Anti-Nausea Pill Could Be a Game-Changer for Hard-To-Treat Breast Cancers

An anti-nausea drug might cut back recurrence and demise in aggressive breast most cancers. Scientists are exploring its broader use in oncology. A latest research has recognized a hyperlink between a broadly used anti-nausea drug and improved outcomes for girls with early-stage breast most cancers, with particularly notable results in these with triple unfavorable breast most cancers. Researchers from […]



Source link